ACTIVE SUBSTANCE / INN

TISOTUMAB VEDOTIN

Brand name(s): Tivdak
EMA LISTED
AUTHORISED
Uterine Cervical Neoplasms
ACTIVE SUBSTANCE
Tisotumab Vedotin
REGULATORS
EMA
SPONSORS / MAH
Genmab A/S
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
TivdakGenmab A/SAuthorised28/03/2025Uterine Cervical Neoplasms

FULL INTELLIGENCE ON TISOTUMAB VEDOTIN

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →